VBI Vaccines Inc. | Mutual Funds
Mutual Funds that own VBI Vaccines Inc.
Eventide Healthcare & Life Sciences Fund
1,850,000
2.88%
0
0.54%
06/29/2018
Vanguard Extended Market Index Fund
727,398
1.12%
0
0%
07/31/2018
Russell US Small Cap Equity Fund
275,285
0.43%
0
0.03%
04/30/2018
APO Medical Opportunities
155,703
0.24%
155,703
0.06%
03/31/2018
FCP OP Medical BioHe@lth-Trends
141,633
0.22%
141,633
0.17%
11/30/2017
Fidelity Spartan Extended Market Index Fund
128,199
0.2%
0
0%
07/31/2018
103,934
0.16%
0
0.08%
04/30/2018
Fidelity Spartan Small Cap Index Fund
69,889
0.11%
1,599
0%
04/30/2018
CREF Stock Account
61,013
0.1%
0
0%
03/31/2018
APO Medical Opportunities Institutionell
59,800
0.09%
0
0.06%
06/29/2018
| Address |
222 3rd Street
Cambridge Massachusetts 02142
United States
|
|
Employees
|
- |
| Website |
http://www.vbivaccines.com |
| Updated |
07/08/2019 |
| VBI Vaccines, Inc. is a biopharmaceutical company, which develops vaccines for infectious disease and immuno-oncology. Its pipeline includes Sci-B-Vac, CMV Vaccine, GBM Immunotherapy, MB Immunotherapy, and Zika Vaccine. The company was founded on July 9, 2015 is headquartered in Cambridge, MA. |
